CLOs on the Move

HeartBeam

www.heartbeam.com

 
HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Ekso Bionics

Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company`s first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable. Ekso Bionics is headquartered in Richmond, CA and is listed on the OTC QB under the symbol EKSO.

GN Otometrics North America

GN Otometrics North America is a Schaumburg, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Atm Laser Products and Services

Atm Laser Products & Services is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

E Medical Group Of Florida

E Medical Group Of Florida is a Mansfield, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

QApel Medical, Inc.

In the simplest sense, we`re a company that creates solutions. More specifically, we design novel access device technology for neurovascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers.